ISSX New Investigator Group Fireside Chat with Dr. Eric Chan

ISSX New Investigator Group Fireside Chat with Dr. Eric Chan

The ISSX New Investigator Group will present this Fireside Chat with Dr. Eric Chan, an influential scientist in the field. This chat session will be moderated by a member of the group and the discussion will include wide-ranging topics such as current scientific trends, leveraging your network, and thinking strategically about your career in industry, academia, and/or government.

About the Speaker:

Dr. Eric Chan is a professor at the Department of Pharmacy and Pharmaceutical Sciences, National University of Singapore. He received his Ph.D. from the same department and was a postdoctoral research scientist at S*BIO Pte Ltd, a joint venture between the Economic Development Board of Singapore and Chiron Corporation at Emeryville, California. As professor, his research interests are (1) metabolism-driven systems biology modelling of diseases, pharmacology, toxicology and mammalian host-bacteria interactions and (2) xenobiotic-derived reactive metabolite research with specific focus on interaction with biological proteins and physiological-based pharmacokinetics-pharmacodynamics (PBPK-PD) modelling of pharmacology and toxicology. He advocates #LearningWithoutBarrier and has been sharing his knowledge generously via his #WeeklyDoseOfPK in LinkedIn. 

Eric Chan

Dr. Eric Chan is a professor at the Department of Pharmacy and Pharmaceutical Sciences, National University of Singapore. He received his Ph.D. from the same department and was a postdoctoral research scientist at S*BIO Pte Ltd, a joint venture between the Economic Development Board of Singapore and Chiron Corporation at Emeryville, California. As professor, his research interests are (1) metabolism-driven systems biology modelling of diseases, pharmacology, toxicology and mammalian host-bacteria interactions and (2) xenobiotic-derived reactive metabolite research with specific focus on interaction with biological proteins and physiological-based pharmacokinetics-pharmacodynamics (PBPK-PD) modelling of pharmacology and toxicology. He advocates #LearningWithoutBarrier and has been sharing his knowledge generously via his #WeeklyDoseOfPK in LinkedIn.

Key:

Complete
Failed
Available
Locked
ISSX New Investigator Group Fireside Chat with Dr. Eric Chan
05/09/2024 at 5:30 PM (EDT)  |  Recorded On: 05/09/2024
05/09/2024 at 5:30 PM (EDT)  |  Recorded On: 05/09/2024 Dr. Eric Chan is a professor at the Department of Pharmacy and Pharmaceutical Sciences, National University of Singapore. He received his Ph.D. from the same department and was a postdoctoral research scientist at S*BIO Pte Ltd, a joint venture between the Economic Development Board of Singapore and Chiron Corporation at Emeryville, California. As professor, his research interests are (1) metabolism-driven systems biology modelling of diseases, pharmacology, toxicology and mammalian host-bacteria interactions and (2) xenobiotic-derived reactive metabolite research with specific focus on interaction with biological proteins and physiological-based pharmacokinetics-pharmacodynamics (PBPK-PD) modelling of pharmacology and toxicology. He advocates #LearningWithoutBarrier and has been sharing his knowledge generously via his #WeeklyDoseOfPK in LinkedIn.
You must register to access.